Involvement of the coding sequence for the estrogen receptor gene in autologous ligand-dependent down-regulation
- PMID: 8413312
- DOI: 10.1210/mend.7.7.8413312
Involvement of the coding sequence for the estrogen receptor gene in autologous ligand-dependent down-regulation
Abstract
The estrogen receptor (ER) appears to be down-regulated by its own ligand in some estrogen (E2)-responsive tissues as well as in cell lines such as MCF-7 and GH3. Surprisingly, we observed ER down-regulation in a newly constructed E2-responsive cell line (Rat1 + ER), in which expression of the coding region of the ER cDNA was driven by the Moloney murine leukemia virus long terminal repeat. We present evidence that the coding region of the ER cDNA, but not the Moloney murine leukemia virus long terminal repeat, possesses a sequence(s) necessary for ER down-regulation. The observed down-regulation occurs at ligand-binding and protein, as well as mRNA, levels. Marked decreases in both protein and mRNA levels were observed as early as 3 h after E2 treatment. Furthermore, maximal down-regulation occurred by 18-24 h with ligand-binding, and mRNA levels reached approximately 20% that of controls. ER down-regulation in Rat1 + ER cells is only partially inhibited by the presence of cycloheximide and therefore suggests a direct participation of the ER in this process. E2 does not appear to influence the stability of the ER transcript, which implies that negative regulation is occurring at the transcriptional level. Finally, since we can demonstrate ER binding to a portion of the cDNA sequence, we propose a mechanism whereby ER binding to its putative negative element leads to transcriptional repression of the upstream promoter.
Similar articles
-
Models of estrogen receptor regulation by estrogens and antiestrogens in breast cancer cell lines.Cancer Res. 1996 May 15;56(10):2321-30. Cancer Res. 1996. PMID: 8625307
-
Activation of the silent progesterone receptor gene by ectopic expression of estrogen receptors in a rat fibroblast cell line.Biochemistry. 1993 Aug 17;32(32):8348-59. doi: 10.1021/bi00083a039. Biochemistry. 1993. PMID: 8347631
-
Regulation of estrogen receptor messenger ribonucleic acid and protein levels in human breast cancer cell lines by sex steroid hormones, their antagonists, and growth factors.Mol Endocrinol. 1989 Feb;3(2):295-304. doi: 10.1210/mend-3-2-295. Mol Endocrinol. 1989. PMID: 2785242
-
Bimodal regulation of epidermal growth factor receptor by estrogen in breast cancer cells.Endocrinology. 1996 Jul;137(7):2739-47. doi: 10.1210/endo.137.7.8770893. Endocrinology. 1996. PMID: 8770893
-
An estrogen receptor-alpha splicing variant mediates both positive and negative effects on gene transcription.Mol Endocrinol. 2000 May;14(5):634-49. doi: 10.1210/mend.14.5.0460. Mol Endocrinol. 2000. PMID: 10809228
Cited by
-
Molecular aspects of estrogen receptor variants in breast cancer.Breast Cancer Res Treat. 1995 Sep;35(3):233-41. doi: 10.1007/BF00665974. Breast Cancer Res Treat. 1995. PMID: 7579493 Review.
-
The Estrogen Receptor α-Cistrome Beyond Breast Cancer.Mol Endocrinol. 2016 Oct;30(10):1046-1058. doi: 10.1210/me.2016-1062. Epub 2016 Aug 4. Mol Endocrinol. 2016. PMID: 27489947 Free PMC article. Review.
-
PTTG expression in different experimental and human prolactinomas in relation to dopaminergic control of lactotropes.Mol Cancer. 2007 Jan 12;6:4. doi: 10.1186/1476-4598-6-4. Mol Cancer. 2007. PMID: 17222350 Free PMC article.
-
[Leu5]enkephalin-encoding sequences are targets for a specific DNA-binding factor.Proc Natl Acad Sci U S A. 1995 Sep 26;92(20):9024-8. doi: 10.1073/pnas.92.20.9024. Proc Natl Acad Sci U S A. 1995. PMID: 7568065 Free PMC article.
-
A novel 80 kDa human estrogen receptor containing a duplication of exons 6 and 7.Nucleic Acids Res. 1996 Mar 1;24(5):962-9. doi: 10.1093/nar/24.5.962. Nucleic Acids Res. 1996. PMID: 8600466 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources